Результаты поиска

Perspective recommendations on geriatric support for older adults with multiple myeloma based on challenges faced by a multidisciplinary team.

BACKGROUND: Multiple Myeloma (MM) predominantly affects older adults, with a median diagnosis age of 70 years, posing challenges in management due to frailty, comorbidities, and age-related physiological changes. As the aging population grows, the prevalence of MM in older patients is expected to rise, requiring improved clinical strategies. METHODS: This consensus report outlines a multidisciplinary framework for the identification, geriatric assessment (GA), and management of older adults with MM, emphasizing the role of frailty assessments, such as the IMWG frailty score, in tailoring trea

From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents.

The potential for the use of antimicrobial peptides (AMPs) as anticancer agents has garnered much interest because of their selective cytotoxicity to tumor cells and ability to evade multidrug resistance mechanisms. AMPs are shorter cationic amphiphilic molecules, part of our innate immune system, with direct membrane-disruptive activity and immunomodulatory effects. Anticancer peptides (ACPs) can be derived from natural biophysical sources or synthetically engineered, taking advantage of the unique biophysical properties of cancer cell membranes to exert their anti-tumor activities rapidly an

Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study.

BackgroundWearable sensors could be a simple way to quantify and characterize mobility in patients with hematologic cancer scheduled to receive autologous hematopoietic stem cell transplant (autoHSCT) and how they may be related to common treatment-related symptoms and side effects of induction chemotherapy.ObjectiveWe aimed to conduct a cross-sectional study comparing mobility in patients scheduled to receive autoHSCT with that in healthy, age-matched adult controls and determine the relationships between patient mobility and chemotherapy-related symptoms.MethodsPatients scheduled to receive

Адаптивные дизайны в случайных клинических испытаниях: повторный анализ теста HOVON87/NMSG18 с несколькими миеломами.

РУКОВОДЯЩИЕ ПРИНЦИПЫ: Случайные контролируемые испытания являются золотым стандартом для оценки клинической эффективности новых лекарственных средств, однако повышение уровня выживания ведет к увеличению времени, необходимого для последующей деятельности, и ставит под сомнение их осуществимость. Адаптивные экспериментальные проекты, предусматривающие проведение более ранних оценок результатов, могут повысить эффективность и ускорить процесс принятия решений. Мы ретроспективно проанализировали, применяются ли адаптивные конструкции к случайному испытанию этапа III HOVON87/NMSG18 (исключение в п

Широкие метастазы грудной клетки и стенки грудной клетки в качестве первоначального представления о раке молочной железы: доклад по делу и обзор литературы.

Метастатическое участие костей остается наиболее распространенной формой дальнего метастаза в раке груди, главным образом из-за анатомических и функциональных характеристик грудного позвоночника, ребер и грудины. Эти структуры примечательны высоким содержанием красного костного мозга, богатой сосудистой системы и их связью с венозным сплексом Бэтсона, что способствует их раннему участию в онкологическом распространении. В некоторых случаях многочисленные метастазы в грудном скелете могут представлять собой первое и единственное клиническое проявление недиагностированного злокачественного проце

Ассоциация традиционной физической терапии больных с множественным склерозом: доклад по делу.

Было упомянуто о том, что 55-летняя женщина с множественным склерорисом (MS) проходит курс обычной физиотерапии и когнитивно-роботной реабилитации. Неврологический анализ выявил атаксическую походку, дисметрию, нейстагмус, когнитивное нарушение внимания и памяти, слабость четырёх конечностей. Для того чтобы улучшить баланс и навыки ходьбы, было предписано проведение 20 занятий по реабилитации на основе традиционной физиотерапии и виртуальной реальности. Результаты были оценены с помощью весовых и пешеходных испытаний и с помощью объективного испытания C-GAIT. В докладе по этому делу показано у

Novel Immunotherapies for Myasthenia Gravis.

Myasthenia gravis (MG), a prototype autoimmune neurological disease, had its therapy centred on corticosteroids, non-steroidal broad-spectrum immunotherapy and cholinesterase inhibitors for several decades. Treatment-refractory MG and long-term toxicities of the medications have been major concerns with the conventional therapies. Advances in the immunology and pathogenesis of MG have ushered in an era of newer therapies which are more specific and efficacious. Complement inhibitors and neonatal Fc receptor blockers target disease-specific pathogenic mechanisms linked to myasthenia and have pr

Clinical application of minimal residual disease detection by ctDNA testing in non-small cell lung cancer: a narrative review.

Background and objectiveIn recent years, significant advancements have been achieved in the treatment of non-small cell lung cancer (NSCLC), leading to prolonged patient survival; however, a subset of NSCLC patients may experience recurrence or distant metastasis following initial successful treatment. This phenomenon may be attributed to the presence of minimal residual disease (MRD) that remains undetectable by conventional imaging or laboratory techniques post-treatment. The potential sources of tumor recurrence (MRD), are significantly associated with adverse patient prognosis; therefore,

Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies.

Cancer-associated thrombosis is one of the most common and serious complications in oncology patients, contributing significantly to morbidity and mortality. This prothrombotic state is driven by cancer-related factors, systemic inflammation, and treatment-induced endothelial injury. Anticoagulation management in these patients is challenging, as both thrombotic and bleeding risks must be carefully balanced, particularly in those with cardiovascular comorbidities. This review examines the complexities of anticoagulation in cancer-associated thrombosis through three clinical cases. Case 1 focus

Measurement Properties of Patient-Reported Outcome Measures for Adolescent and Young Adult Survivors of a Central Nervous System Tumor: A Systematic Review.

Purpose: To identify and evaluate patient-reported outcome measures (PROMs) for assessing survivorship-related concepts for adolescent and young adult (AYA) survivors of central nervous system (CNS) tumors. Methods: We searched five electronic databases. Two researchers independently screened all titles for inclusion and used consensus-based standards for the selection of health measurement instruments (COSMIN) guidance to grade the quality of evidence for each measurement property. Results: Four studies met eligibility criteria: single-item pain thermometer; single-item fatigue thermometer; 3

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.

OBJECTIVE: Vacuoles E1 enzyme X-linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality. METHODS: Given the variability in disease presentation and the limited number of studies to date, no clinical documents currently exist to provide guidance to health care providers about the management of VEXAS. To address this gap, we formed an international multidisciplinary panel of VEXA

Use of Cement-Augmented Percutaneous Pedicular Screws in the Management of Multifocal Tumoral Spinal Fractures.

STUDY DESIGN: Retrospective case series observational study. PURPOSE: Cancer patients are often aged and are further weakened by their illness and treatments. Our goal was to evaluate the efficiency and safety of using minimally invasive techniques to operate on spinal fractures in these patients. OVERVIEW OF LITERATURE: Vertebroplasty is now considered to be a safe technique that allows a significant reduction of the pain induced by a spinal tumoral fracture. However, few papers describe the kyphosis reduction that can be achieved by combining percutaneous fixation and anterior vertebral re

Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol.

Celastrol (CEL) is a natural pentacyclic triterpenoid demonstrating significant therapeutic properties against various diseases. However, the ambiguity of target information poses a significant challenge in transitioning CEL from a traditional remedy to a modern pharmaceutical agent. Recently, the emerging target discovery approaches of natural products have broadened extensive avenues for uncovering comprehensive target information of CEL and promoting its drug development. Herein, diverse target discovery strategies are overviewed for the pharmacological and toxicological studies of CEL, inc

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting.

Substantial improvements in survival have been seen in multiple myeloma (MM) over recent years, associated with the introduction and widespread use of multiple novel agents and regimens, as well as the emerging treatment paradigm of continuous or long-term therapy. However, these therapies and approaches may have limitations in the community setting, associated with toxicity burden, patient burden, and other factors including cost. Consequently, despite improvements in efficacy in the rigorously controlled clinical trials setting, the same results are not always achieved in real-world practice

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic.

Multiple myeloma (MM) is an incurable hematological malignancy with significant clinical and biological heterogeneity. Despite development and refinement of numerous prognostic models for MM, challenges with accurate and reliable risk stratification remain, highlighted by unexpected, early relapse or progression of disease in patients termed functional high-risk (FHR). To improve decision-making and optimise outcome, there is an unmet need for precise identification of high-risk (HR) patients, to enable tailored therapeutic strategies. With a complex and rapidly evolving treatment landscape, a

Изучение механизмов контроля баланса у людей с множественным склерозом в виртуальной реальности: систематический обзор.

ЦЕЛЬ: Множественный склероз (МС) снижает контроль за балансом, сказываясь на мобильности и качестве жизни. Виртуальная реальность (ВПР) открывает новые возможности для изучения механизмов сбалансированности и потенциальной реабилитации. В рамках этого обзора изучается контроль баланса у пациентов с НР с использованием VR, при этом проводится сопоставление ответов в VR и не VR-режимах с ответами со здоровым контролем. МЕТОДЫ: Этот систематический обзор проводился в соответствии с руководящими принципами ПРИСМА. Всесторонний поиск проводился по базам данных, включая PubMed, Web of Science, Scopu

Complete response after autologous stem cell transplant in multiple myeloma.

We evaluated long-term outcome of patients achieving complete response (CR) after autologous stem cell transplantation (ASCT) for multiple myeloma. Between April 1990 and June 2012 191 patients underwent ASCT. The median age was 53 years (range, 26-68 years), 135 were men. Pretransplant, patients received induction therapy with VAD (vincristine, doxorubicin, dexamethasone; n = 77), novel agents (n = 92), or alkylating agent-based, n = 22); 43% received more than one line of induction regimen. Response to transplant was defined as per EBMT criteria. The median follow-up for the entire group was

Agreement between the EQ-5D-5L anxiety/depression dimension and GAD-7/PHQ-9 for psychological distress assessment in patients with hematologic malignancies.

BACKGROUND: Patients with hematologic malignancies (HMs) often experience psychological distress, significantly impairing health-related quality of life (HRQoL) and deteriorating clinical prognosis. Although the widely used instrument EuroQol 5-Dimension 5-Level (EQ-5D-5L) has been validated in the general population for accurately identifying the psychological symptoms, its performance in HM patients remains unclear. We aimed to investigate whether the EQ-5D-5L questionnaire anxiety/depression (A/D) dimension, when already collected for HRQoL assessment, correlates with anxiety and depression

Совпадение в полном тексте источника
… Toussaint A Sensitivity to change and minimal clinically important difference of the 7-item generalized anxiety disorder questionnaire (GAD-7) Journal of Affective Disorders 2020 265 395 401 10.1016/j.jad.2020.01.032 32090765 Toussaint, A., et al. (2020). … Sensitivity to change and minimal clinically important difference of the 7-item generalized anxiety disorder questionnaire (GAD-7). Journal of Affective Disorders, 265 , 395–401. 32090765 10.1016/j.jad.2020.01.032 10. …

Тандем автологическая трансплантация стволовых клеток у нескольких пациентов миэломы с минимальными остаточными заболеваниями: взрывное исследование.

Объективная аутологическая трансплантация стволовых клеток (tASCT) является жизнеспособным вариантом для пациентов с множественным миэломой (MM) повышенного риска. Минимальная остаточная болезнь (МСД), являющаяся суррогатным показателем бремени заболеваний в режиме реального времени, служит ценной мерой реагирования на эти заболевания. В ходе этого исследования была проведена оценка воздействия TAST на динамику MRD у пациентов MM.MetodsWe анализ данных из многоцентрового реестра 28 пациентов, прошедших ТАШТ в качестве прифронтового лечения в период с января 2019 и октябрь 2024. Критерии предос

Internet-based guided self-help for glioma patients with depressive symptoms: design of a randomized controlled trial.

BackgroundAmong glioma patients, depression is estimated to be more prevalent than in both the general population and the cancer patient population. This can have negative consequences for both patients and their primary informal caregivers (e.g., a spouse, family member or close friend). At present, there is no evidence from randomized controlled trials for the effectiveness of psychological treatment for depression in glioma patients. Furthermore, the possibility of delivering mental health care through the internet has not yet been explored in this population. Therefore, a randomized contro